FDA

By leveraging the unnecessary Emergency Use Authorization (EUA), the FDA is pushing forward with an experimental vaccine booster based on limited safety and efficacy data.

Statement by Dr. Paul Marik on the Dismissal of Lawsuit Against FDA Over Ivermectin

Christine Dolan talks FDA, CDC and Fauci with Dr. Pierre Kory and Dr. Meryl Nass as part of CD Media's In Plain Sight livestream.

Dr. Paul Marik, Dr. Mary Talley Bowden and Dr. Robert L. Apter challenge the FDA regarding ivermectin as a COVID treatment.

This article, by John Roulac, explores how American perceptions of the FDA have changed and what this faith has delivered to our nation.

In "Horse-Bleep: How 4 Calls on Animal Ivermectin Launched a False FDA-Media Attack," investigative reporters Pfeiffer and Bonvie dug up FDA emails documenting the start of the coordinated, mass propaganda campaign against IVM — and got The New York Times to correct its false reporting about it.

Speaking with the Infinity Foundation, Dr. Marik discusses how Big Pharma invests millions to suppress data that can hinder their profits.

Israeli Scientist says COVID-19 Could be Treated for less than $1/Day reviews a Jerusalem Post Double-blind study

The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.